Exploring the TIL Trial: Sophie's Story | The Eye Believe Podcast

In this episode of the Eye Believe Podcast, we’re joined by Sophie Cantu, who shares her personal experience participating in a TIL (Tumor-Infiltrating Lymphocyte) clinical trial for ocular melanoma.   After previous treatments were unsuccessful, Sophie enrolled in the TIL trial—and saw encouraging results, including tumor shrinkage. She speaks candidly about what led her to the trial, what the experience was like, and how it changed her outlook moving forward.   Sophie’s story offers hope to patients and families navigating treatment decisions and highlights the importance of continued research and clinical trials in advancing options for ocular melanoma.   Tune in to hear Sophie’s journey, her perspective on perseverance, and why sharing patient experiences matters.   NCT pages for trials mentioned: TIL TRIAL - https://www.clinicaltrials.gov/study/NCT03467516 IDEAYA TRIAL - https://www.clinicaltrials.gov/study/NCT05987332 RP2 TRIAL - https://clinicaltrials.gov/study/NCT06581406   Sophie Socials: https://www.facebook.com/SophieStevens9 https://www.instagram.com/sophiegstevenscantu/